Diphtheria situational report (week 46 of 2026)

Between 29 December 2025 and 15 November 2026, 49 confirmed cases of respiratory diphtheria and 15 asymptomatic carriers of toxigenic C. diphtheriae have been identified in South Africa. Most confirmed cases were reported from the Western Cape (78%; 38/49), followed by Limpopo (10%; 5/49) and Gauteng (12%; 6/49). Asymptomatic carriers were reported from the Western Cape (80%; 12/15), Limpopo (13%; 2/15) and Gauteng (7%; 1/15). Six probable cases were reported, five from Limpopo and one from the Western Cape.

Highlights:

  • Since the last situational report (week 45, 2026), the following updates are included in this report
    • Two new laboratory-confirmed cases of toxigenic diphtheria from the Western Cape.
    • One new probable respiratory diphtheria case from the Western Cape.
    • Four new asymptomatic carriers of toxigenic C. diphtheriae from the Western Cape.
  • Appropriate public health responses were initiated for all suspected and confirmed cases.

Information for clinicians

Clinical presentation of respiratory diphtheria

Respiratory diphtheria is a vaccine-preventable illness caused by toxigenic C. diphtheriae (and more rarely C. ulcerans or C. pseudotuberculosis), and can occur in persons of all ages.

The clinical presentation includes the following signs and symptoms:

  • sore throat
  • low-grade fever
  • AND an adherent membrane of the nose, pharynx, tonsils, or larynx – the membrane is greyish-white and firmly adherent to the tissue
  • AND/OR enlarged glands in the neck (bull neck)
  • toxin-mediated systemic signs including myocarditis, polyneuropathy and renal damage

Patient management
Treatment includes antibiotics (azithromycin or penicillin) to clear the organism from the throat and prevent onward transmission, and diphtheria anti-toxin (DAT) to neutralise unbound toxin. The dosage of DAT is determined by the duration and severity of illness. Treatment, contact tracing and chemoprophylaxis should be started prior to laboratory confirmation. Early administration of DAT may be life-saving and should not be delayed in cases with a high index of suspicion. Supportive care is primarily aimed at airway management and includes providing oxygen, monitoring with electrocardiogram and intubation or performance of a tracheostomy if necessary.

To access previous diphtheria situational reports, click here.

READ THE FULL UPDATE HERE

Diseases A-Z Index

RECENT POSTS

SHARE

Share on facebook
Share on twitter
Share on linkedin